I3J=/<,.C|W%CK7HK'5BA{IWDA
SYSTEM PROCESSING...
I3J=/<,.C|W%CK7HK'5BA{IWDA
SYSTEM PROCESSING...
Posted: 2025-04-17 00:10:41 UTC
We use a score to evaluate content reliability. This article's score is high enough, and there are no largely false claims identified in this rollup.
We use a score to evaluate content reliability. This article's score is high enough, and there are no largely false claims identified in this rollup.
Status
Last Updated
2025-04-17 00:10:57 UTC
Verified By
Rollup News
A large, long-term trial found that Exenatide, a GLP-1 drug, did not provide significant benefits for Parkinson's Disease. No improvements were seen in movement, symptoms, or brain imaging over 96 weeks.
Exenatide shows no significant benefits for Parkinson's Disease
No improvements in movement, symptoms, or brain imaging were observed
Trial duration of 96 weeks
Lack of improvement in motor skills
No reduction in Parkinson's symptoms
Absence of positive changes in brain imaging